Chapter: Basic & Clinical Pharmacology : Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics,& Drugs Used in Gout

Interleukin-1 Inhibitors

Drugs targeting the interleukin-1 pathway, such as anakinra, canakinumab, and rilonacept, are being investigated for the treat-ment of gout.

INTERLEUKIN-1 INHIBITORS

Drugs targeting the interleukin-1 pathway, such as anakinra, canakinumab, and rilonacept, are being investigated for the treat-ment of gout. Although the data are limited, these agents may provide a promising treatment option for acute gout in patients with contraindications to, or who are refractory to, traditional therapies like NSAIDs and/or colchicine. A recent study suggests that canakinumab, a fully human anti-IL-1β monoclonal anti-body, can provide rapid and sustained pain relief at a dose of 150 mg subcutaneously. These medications are also being evalu-ated as therapies for prevention of gout flares while initiating urate-lowering therapy.

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail

Basic & Clinical Pharmacology : Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics,& Drugs Used in Gout : Interleukin-1 Inhibitors |